Formulation,
Optmization and Evaluation of Curcuma longa and Piper nigrum
Hydrogel
Mohammed
Aslam Mohammed Azam*, Dr. Sandeep A. Wathore,
Dr.
Umesh T Jadhao
Department of Pharmaceutics, SVP College of Pharmacy,
Hatta TQ Basmat Dist. Hingoli (M.S) India
Correspondence: mohammedaslambagban@gmail.com
DOI: https://doi.org/10.71431/IJRPAS.2026.5615
|
Article
Information
|
|
Abstract
|
|
Research Article
Received: 08/06/2026
Accepted:
13/06/2026
Published:30/06/2026
Keywords
Antibacterial activity; Antioxidant activity;
Curcuma longa; Hydrogel;
Piper nigrum; Phytochemical screening; Topical
delivery.
|
|
The present work aimed to
formulate and evaluate a topical herbal hydrogel with methanolic extracts of
Curcuma longa and Piper nigrum. The extracts were prepared using maceration
with methanol followed by phytochemical screening and incorporated into
hydrogel bases prepared with sodium alginate, chitosan, Carbopol 934, or HPMC
K100M. FTIR analysis revealed compatibility between the extracts and
excipients, and the prepared formulations were evaluated for appearance, pH,
viscosity, spreadability, swelling index, extrudability, antioxidant activity,
anti-inflammatory activity, and antibacterial activity. The formulations
remained physically stable and showed skin-compatible pH values between 6.21
and 6.51. Among all batches, F9 demonstrated the most favourable performance,
with the highest swelling index, antioxidant activity (78.5%),
anti-inflammatory activity (74.2%), and appreciable antibacterial activity
against Staphylococcus aureus and Escherichia coli. These findings suggest
that the optimized polyherbal hydrogel may serve as a promising topical
delivery system for localized management of skin-related inflammatory and
microbial conditions.
|
INTRODUCTION
Herbal medicines have been the basis of traditional medical systems
throughout Asia, Africa and other regions for centuries and they remain an
important part of primary healthcare today globally.[1] The World Health
Organization indicates that a large proportion of the world relies
on herbal medicines because they are often easily
obtainable, inexpensive, and culturally acceptable,
particularly in low- and middle-income countries.[2-3] In
addition to their historical importance, medicinal plants harbour a large pool
of bioactive secondary metabolites that directly or indirectly contributed to
the identification and development of novel drugs such as artemisinin and other
plant-derived cytotoxic and anti-inflammatory agents.[2,4] The effective
integration of herbal medicines into evidence-based healthcare continues to be
limited by aspects like species and geography-specific variability in
phytochemical composition as well as processing conditions, lack of
standardized extraction and quality-control protocols, potential herb–drug
interactions, and poor availability of adequate high-quality clinical data.
However, conventional forms of delivery for phytoconstituents yield distinctly
suboptimal bioavailability and therapeutic responses due to inadequate solubility,
membrane permeability and plasma half-lives, as well as high rates of
metabolism.[3-4] These limitations highlight the importance of scientific
validation, standardization, and rational formulation design to ensure their
safety, efficacy and reproducibility. [4].
Curcuma longa
L. (family Zingiberaceae), commonly known as turmeric, is a rhizomatous
perennial herb widely cultivated in India and other tropical regions and
extensively used as a culinary spice, colouring agent, and traditional
remedy.[5,6] The dried rhizomes of C. longa contain a characteristic
yellow pigment fraction composed predominantly of curcuminoids, including
curcumin, dimethoxy curcumin, and bisdemethoxycurcumin, along with essential
oils rich in turmerones and other volatile constituents.[5,6] Curcumin, the
principal polyphenolic curcuminoid, has been extensively investigated and shown
to possess broad pharmacological activities, including potent antioxidant,
anti-inflammatory, antimicrobial, wound-healing, hepatoprotective, and immunomodulatory
effects.[5-7] In the context of dermatology and cutaneous health, curcumin
modulates multiple cellular pathways related to oxidative stress, inflammatory
cytokine production, collagen synthesis, and melanogenesis, supporting its
potential utility in conditions such as acne, psoriasis, atopic dermatitis,
photodamage, and wound repair.[6,8] These pleiotropic effects, combined with a
generally favourable safety profile, have made turmeric and curcumin attractive
candidates for incorporation into pharmaceutical and cosmeceutical
formulations, particularly for topical and localized therapy.[6,8]
Fig.
1. Curcuma Longa
Although curcumin displays an interesting pharmacological profile, there
are many biopharmaceutical limitations preventing its clinical use. [7-9] It
shows highly poor aqueous solubility, low stability in physiological media,
high pre-systemic metabolism and fast systemic clearance leading to very low
oral and systemic bioavailability.[7,9,10]
Various formulation strategies—including solid dispersions, lipid-based
carriers, nanoparticles, and phospholipid complexes—have been explored to
enhance curcumin solubility, permeability, and therapeutic efficacy.[9-11] In
the topical domain, advanced delivery systems such as hydrogels and nanoparticulate
carriers have been reported to improve the retention, controlled release, and
local effectiveness of curcumin for the management of skin disorders.[12,6,8]
Nevertheless, there remains a need for simple, patient-friendly, and stable
topical dosage forms capable of enhancing the local availability of
curcuminoids at the site of application.
Piper nigrum L. (family Piperaceae) is commonly known as black
pepper. It is another widely used spice and medicinal plant with a long history
of use in traditional medicine as a digestive stimulant, carminative, and
general health-promoting agent.[13,14] Its principal pungent alkaloid,
piperine, is responsible for its characteristic taste of black pepper and has
been recognized as the major bioactive constituent.[13,14] Pharmacological
studies have shown piperine to possesses diverse biological activities, with
antioxidant, anti-inflammatory, antimicrobial, immunomodulatory,
hepatoprotective, and anticancer effects.[13,14] Piper nigrum extracts
and piperine-containing formulations have also been investigated for their
analgesic and anti-nociceptive properties, including in transdermal and topical
delivery systems designed for pain relief.[15]
Fig. 2. Piper nigrum
One of the most vital trait of
piperine is that it works as a bioavailability enhancer for diverse medicinal
drugs and phytoconstituents.[14,16] As such, piperine has been shown to alter
membrane dynamics, inhibit efflux transporters (e.g., P-glycoprotein), and
inhibit drug metabolizing enzymes which can increase the absorption and
systemic exposure of co-administered agents.[14,16] Multiple studies have documented the enhancement of
curcumin bioavailability and pharmacokinetic profiles after co-treatment with
piperine, along with therapeutic response to other poorly absorbed molecules.
[17,14] To exploit this bio enhancing effect, a number of solid dispersion-based
microparticles or other delivery systems containing Curcuma longa as well as
Piper nigrum extracts have been formulated with improved dissolution and
release characteristics for both curcumin and piperine.[18,17,19] These
findings strongly substantiates the scientific foundation of rational
combinations with curcumin.
Polyherbal formulations of Curcuma
longa and Piper nigrum are similarly gaining interest in current
phytopharmaceutical research and plays an integral role in traditional medical
systems such as Ayurveda and Traditional Chinese Medicine and are increasingly
being revisited within modern phytopharmaceutical research.[2-3] With a view
towards utilizing the synergistic or additive effects of the different plant
constituents to achieve multiple molecular targets and pathways, expanding the
therapeutic spectrum and minimizing the dosage requirement for these individual
components.[4,2] Polyherbal
combinations can also provide complementary pharmacological activities, such as
simultaneous antioxidant, anti-inflammatory, antimicrobial, and wound-healing
effects, which are particularly advantageous for complex, multifactorial
conditions.[4,20] With the specific case of Curcuma longa and Piper
nigrum, curcumin contributes strong antioxidant and anti-inflammatory
actions, while piperine not only exerts similar pharmacological effects but can
also enhance the bioavailability and penetration of curcumin and other
curcuminoids.[5,17,14] Altogether, these plants may provide a complementary and
potentially synergistic approach in the management of inflammation, oxidative
stress, microbial contamination, and tissue repair in skin-related disorders,
especially when delivered directly to the affected site.
Topical drug delivery is attractive for
the delivery of herbal actives for the treatment of the topical skin
conditions, wounds, infections or inflammatory disorders.[21,22] Since they
provide direct access for their action on the target site, reducing systemic
exposure and allow the minimization of systemic adverse effects.[21-23] From a
patient's convenience point of view, topical formulation are often non-invasive
and convenient to use, and are associated with good compliance with the topical
delivery, particularly for topical oral and skin diseases, which need long term
daily treatment. [21-23]
A variety of topical dosage forms are
available, including creams, ointments, lotions, gels, and hydrogels, each with
distinct rheological and sensory properties.[21,22] The high water contents and
the advantageous physiological factors of hydrogels, like their soothing and
cooling effects, skin compatibility, and ease of application, have made
hydrogels a growing field of interest in the delivery of herbals and synthetic
drugs applied to inflamed or irritated skin, where comfort to the patient and
ease of application are crucial factors to consider when designing a drug
delivery system.[21,22]
Hydrogels are 3D, cross-linked polymeric
networks, which are capable of absorbing and retaining large quantities of
water or biological fluids while maintaining their structural integrity.[24,22]
Their high water content and tunable network structure also enable them to
mimic the properties of soft tissues and to provide a moist microenvironment,
which is beneficial for wound healing and epithelial regeneration.[21,22] From
a drug-delivery perspective, hydrogels can function as controlled-release
systems, allowing modulation of drug loading, diffusion, and release kinetics
by altering the polymer composition, cross-linking density, and network
architecture.[24,22]
Different
types of natural and synthetic polymers were used for the formulation of
hydrogels, including carbopol (carbomer), hydroxypropyl methylcellulose (HPMC),
sodium alginate, and chitosan, among others.[21,24,25] Such gelling agents
differ in their swelling behavior, viscosity, bioadhesiveness, mechanical
strength, and permeability, and hence influence the critical topical
performance parameters such as spreadability, extrudability, residence time,
and drug-release profile.[21,23,26] Hydrogels formulated using alginate and
chitosan, often in combination, have shown promising outcomes as wound
dressings and drug carriers, offering biocompatibility, intrinsic antimicrobial
activity, and the ability to provide sustained release of incorporated
agents.[24,25,26] Consequently, hydrogel-based systems are being widely
explored in contemporary pharmaceutical research for applications in wound
healing, antimicrobial therapy, anti-inflammatory treatment, and broader
dermatological indications.[21,24,22]
Incorporation
of herbal extracts into the formulations could be a good approach for enhanced
topical delivery and local bioavailability of phytoconstituents. [21-22]
Methanolic extracts of Curcuma longa have been observed to possess a wide diversity of secondary metabolites in
different phytochemical classes such as curcuminoids and phenolic compounds and
other secondary metabolites with strong antioxidant and anti-inflammatory
properties.[5-6] Similarly, Piper nigrum extracts are also rich
in piperine and other phenolic and alkaloidal constituents that play a role in
antioxidant, antimicrobial, analgesic actions as well as bioavailability
enhancement.[13,27] Topical hydrogels of turmeric extracts were evaluated for
phytoconstituents, and qualitative and quantitative evaluations show that
multiple classes of phytoconstituents such as flavonoids,
tannins, steroids, terpenoids, saponins, and glycosides, which may work synergistically to provide multi-targeted
effects [5-6]
Recent studies using Curcuma
longa-derived hydrogels demonstrated the incorporation of methanolic
turmeric extracts into controlled-release hydrogel systems with favourable
physicochemical properties and encouraging antioxidant, anti-inflammatory,
photoprotective, and wound-healing activities.[6] These findings encourage the
need for developing topical formulations based on turmeric-loaded hydrogels to
be utilized in skin care products and dermatological therapy efforts. [6-8] Nonetheless, although piperine is well-known for is
bioenhancing properties and both these extracts have shown compatibility in
oral as well as solid dispersion systems, relatively lesser studies has
reported the use of polyherbal hydrogel containing Curcuma longa along
with Piper nigrum. [18-19] Therefore, a new hydrogel formulation
containing methanolic extracts of both plants could represent an efficient
vector for efficiently delivering several classes of phytoconstituents directly
to the skin and potentially enhancing local therapeutic activity through
complementary antioxidant, antiseptic effects while taking advantage of the
permeation-enhancing and bioavailability-modulating properties of piperine.
Both Curcuma longa and Piper
nigrum have been analysed separately for various pharmacological activity
including antioxidant, anti-inflammatory, antimicrobial, wound-healing
bioavailability-enhancing potential but development of combined topical
hydrogel system with P. nigrum and C. longa methanolic extracts
remains relatively unexplored. [5,6,13,14] Most of these studies have dealt
with oral or systemic formulations, solid dispersions and nanocarriers for
better dissolution and systemic bioavailability of curcumin both in the
presence of piperine but relatively few that may lead to localized
skin-targeted delivery. [18,17,19,14] Hence, systematic formulation
development and compatibility evaluation, as well as complete characterization
of the physicochemical properties of a hydrogel containing Curcuma longa
and Piper nigrum extracts with in vitro assessment of their relevant
biological activities for topical therapy is clearly warranted. [6,22]
Therefore, this study was
aimed to formulate and develop a herbal hydrogel of methanolic extracts of Curcuma
longa and Piper nigrum for topical application. The work aims to optimize a suitable polymeric
hydrogel base for the incorporation of these extracts with respect to key
physicochemical parameters such as appearance, pH, viscosity, spreadability and
extrudability and drug content as well as their in vitro antioxidant,
anti-inflammatory and antimicrobial properties. The current study aims to
investigate the possibility of a herbal topical product that may contain offer
enhanced local therapeutic efficacy for skin-related disorders through combined
and possibly synergistic pharmacological actions.
MATERIALS AND
METHODOLOGY
The plant
materials, Curcuma longa and Piper nigrum, used as active herbal
ingredients were obtained from the locality of Hatta Tal. Basmat Dist. Hingoli,
(M.S), India and the voucher specimen were stored for future use. Sodium
alginate, Carbopol 934, and HPMC K100M were procured from Research-Lab Fine Chem
Industry, while chitosan, methyl paraben, and propyl paraben were obtained from
Loba Chemie Pvt. Ltd., India. Propylene glycol was purchased from Merck Life
Science Pvt. Ltd., India, and sodium hydroxide was procured from Fisher
Scientific, India. All chemicals and reagents used in the study were of
analytical grade and used without further purification.
Extraction
of Curcuma longa and Piper nigrum
The dried
rhizomes of Curcuma longa and dried fruits of Piper nigrum were
washed with distilled water and shade dried and ground into powder separately
in a mechanical grinder. A total of 100 g of each powdered material was
macerated with 500 mL of methanol for 72 h with intermittent shaking for good
phytoconstituents extraction. The extracts were filtered through Whatman No. 1
filter paper and concentrated under reduced pressure using rotary vacuum
evaporator below 40°C. The concentrated extracts were subsequently dried under
water bath to produce semi-solid extracts and kept in a closed, air-tight,
amber coloured containers at 4°C until used. [33-34]
Preliminary
Phytochemical Screening
The methanolic
extracts of Curcuma longa and Piper nigrum were subjected to
qualitative phytochemical screening using standard procedures to determine
various phytoconstituents such as alkaloids, carbohydrates, glycosides,
flavonoids, tannins, phenolic compounds, saponins, steroids, terpenoids,
proteins, and amino acids. The presence or absence of these constituents was
determined based on characteristic colour changes and/or precipitate
formation.[35]
FTIR
Study
The
compatibility of extracts of Piper nigrum and Curcuma longa with
the selected excipients was evaluated using Fourier-transform infrared (FTIR)
spectroscopy. The spectra of the individual extracts and their corresponding
extract–excipient mixtures were recorded in the range of 4000–400 cm⁻¹ at room
temperature. The characteristic functional group peaks were compared for
significant shift, disappearance or appearance of new peaks which might be
occurring due to interaction between the herbal extracts and formulation
excipients. [36]
Formulation
of Herbal Hydrogel
Herbal hydrogel
was prepared by dispersion of the selected polymer into distilled water and
stirring for 24 hours until a uniform gel base form. Propylene glycol was used
to dissolve methanolic extract of Curcuma longa and Piper nigrum
and added to the hydrated polymeric dispersion. Methyl paraben and propyl
paraben were added as preservatives and mixed for evenly dispersion with all
the ingredients by stirring continuously for 10 min. An appropriate pH modifier
was used to adjust the pH and distilled water was used to adjust the volume.
The formulation was then homogenized to achieve a smooth, homogeneous and
lump-free hydrogel. [37-38]
Table 1. Formulation
table for Hydrogel
|
Ingredients (% w/w)
|
F1
|
F2
|
F3
|
F4
|
F5
|
F6
|
F7
|
F8
|
F9
|
F10
|
F11
|
F12
|
|
Curcuma longa extract
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
|
Piper nigrum extract
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
|
Sodium
alginate
|
0.5
|
1.0
|
1.5
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Chitosan
|
—
|
—
|
—
|
0.5
|
1.0
|
1.5
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Carbopol 934
|
—
|
—
|
—
|
—
|
—
|
—
|
0.5
|
1.0
|
1.5
|
—
|
—
|
—
|
|
HPMC K100M
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.5
|
1.0
|
1.5
|
|
Propylene
glycol
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
10.0
|
|
Methyl
paraben
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
|
Propyl
paraben
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
0.02
|
|
pH adjuster
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
q.s.
|
|
Distilled
water
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
q.s. to 100
|
Appearance
and Homogeneity
The prepared
hydrogel formulations were evaluated visually for colour, consistency,
transparency, grittiness, and phase separation. Homogeneity and smoothness were
done by allowing the formulation to be gently rubbed between the fingers to
check for the presence of coarse particles or lumps.
pH
Determination
A calibrated
digital pH meter was used to measure the pH of the hydrogel formulations. The
appropriate amount of gel was suspended in distilled water and allowed to stand
until uniform. The electrode of the pH meter was dipped into the sample and the
reading on the pH meter was noted. Triplicate measurements were made and the
mean obtained. The pH values were kept on physiological range of skin to reduce
possible skin irritation after topical application. [39]
Viscosity
Measurement
The viscosity
of the formulations of hydrogel was measured by using AMETEK Brookfield DV-E™
viscometer using spindle model RV No.4 with 20rpm working rate and temperature
of 25°C ± 1. The spindle was immersed in the beaker containing the sample of
the hydrogel, and equilibrium readings were taken when the system was in a
state of equilibrium. Triplicate measurements were done for all samples, and
the resulting values in terms of viscosity was determined. [40]
Spreadability
Study
The
spreadability of the prepared hydrogels was analysed by the glass slide method.
Equal amount of gel itself was positioned between two glass slides and standard
weight was applied for a fixed amount of time to promote even dispersion. The distance
traversed by the upper slide was then measured and spreadability determined
according to the equation; S = M × L/T, where S is spreadability, M is applied
weight, L is distance moved by slide and T is the time taken. The higher the
spreadability values the efficient of application of the hydrogel on the skin
surface was. [41]
Determination
of Swelling Index
The swelling
behaviour of the hydrogels was evaluated by placing approximately 1 g of the
formulation in 10 mL of 0.1 N sodium hydroxide solution. The swollen gel was
removed at pre-determined intervals, the surface was soaked with water to drain
off excess water and then weighed. The swelling index was calculated using the
ratio of the increase in weight of the swollen gel to its initial weight and
expressed as percentage swelling. [42]
Extrudability
Test
The
extrudability of the hydrogel formulations was evaluated by filling the
prepared gels into collapsible tubes and applying a specified pressure to
extrude the contents. The volume of gel extruded in a specified time period was
measured and the ease of extruding the gel was evaluated. Each formulation
underwent three replicate tests and was calculated to determine the suitability
of the product for convenient dispensing from the container.
In
Vitro Antioxidant Activity
The antioxidant
activity of the hydrogel formulations was evaluated using the DPPH free radical
scavenging assay. DPPH solution was mixed with equal volume of the test samples
and allowed to stand in the dark at room temperature for 30 min. The absorbance
was taken at 517 nm using UV-visible spectrophotometer with ascorbic acid as
reference drug. The percentage inhibition of DPPH radicals was determined using
the decreasing in absorbance value of the control and sample and expressed as
the scavenging activity of the radicals. [43]
In
Vitro Anti-Inflammatory Activity
Egg albumin
denaturation method was used to determine the anti-inflammatory activity of the
herbal hydrogel. Fresh egg albumins fresh were used for the reaction with phosphate
buffers pH 6.4 and different concentrations of test sample. Distilled water was
used as negative control and Diclofenac Sodium used as standard drug. The
protein mixture was incubated at 37°C for 15 min and heated at 70°C for 5 min
to denature the protein. The absorbance was spectrophotometrically measured
after the cooling process and percentage inhibition of protein denaturation was
calculated according to the value of absorbance of the control and sample
solutions. [44] DPPH radical inhibition percentages were determined with the
following formula:
% Inhibition =
[(Absorbance of control − Absorbance of sample) / Absorbance of control] × 100
The antioxidant
potential was expressed as percentage radical scavenging activity, and the IC₅₀
value, if required, was determined from the graph plotted between concentration
and percentage inhibition
In
Vitro Antibacterial Activity
The
antibacterial activity of the hydrogel formulation prepared from methanolic
extracts of Curcuma longa and Piper nigrum was tested by agar
well diffusion method. Sterile nutrient agar plates were prepared and wells,
using a sterile cork borer were made, were inoculated with test microorganisms.
The test formulation was added to the wells, and an antibiotic as positive
control and plain gel base as negative control. The plates were incubated for
24 h at 37°C and the zone of inhibition was in measured in millimetres for the
assessment of antibacterial activity. [44]
3.
RESULT AND DISCUSSION
Preliminary Phytochemical Screening
Alkaloids,
carbohydrates, glycosides, flavonoids, tannins, phenolics, steroids and
terpenoids were identified in methanolic extracts of both Curcuma longa and
Piper nigrum; however proteins and amino acids were not present in
either of the two extracts as saponins was detected only in C. longa (Table
02). This confirms that both extracts contain a wide variety of
secondary metabolites which may have increased the bioactive properties like
antioxidant, anti-inflammatory and antimicrobial potential of the final
hydrogel formulation.
Table 2. Preliminary
Phytochemical Screening of Methanolic Extracts
|
Phytoconstituents
|
Test Performed
|
Curcuma
longa Extract
|
Piper
nigrum Extract
|
|
Alkaloids
|
Mayer’s Test
|
+
|
+
|
|
Dragendorff’s Test
|
+
|
+
|
|
Carbohydrates
|
Molisch’s Test
|
+
|
+
|
|
Benedict’s Test
|
+
|
+
|
|
Glycosides
|
Keller–Killiani Test
|
+
|
+
|
|
Flavonoids
|
Alkaline Reagent
Test
|
+
|
+
|
|
Shinoda Test
|
+
|
+
|
|
Tannins & Phenolics
|
Ferric Chloride Test
|
+
|
+
|
|
Lead Acetate Test
|
+
|
+
|
|
Saponins
|
Foam Test
|
−
|
+
|
|
Steroids & Terpenoids
|
Salkowski Test
|
+
|
+
|
|
Liebermann–Burchard
Test
|
+
|
+
|
|
Proteins & Amino Acids
|
Ninhydrin Test
|
−
|
−
|
(+): Present
(−): Absent
Total
Phenolic Content (TPC)
The total
phenolic content of Curcuma longa extract and Piper nigrum
extract was found to be 86.42 ± 1.18 mg GAE/g
and 71.36 ± 1.05 mg GAE/g, respectively. This indicated that C. longa
was found richer in terms of phenolic compounds in the present study. The
higher level of phenolics is due to their contribution towards free-radical
scavenging as phenolic compounds are strong antioxidant potential. The gallic
acid calibration curve showed excellent linearity (Fig 03), confirming the
reliability of the assay.
Fig. 3. Calibration
curve for Galic acid
Total
Flavonoid Content (TFC)
The total
flavonoid content of the extracts of C. longa was higher at 64.78 ± 0.94
mg QE/g than that of P. nigrum at 52.63 ± 0.88 mg QE/g, which indicates
that more flavonoid-rich phytoconstituent to the formulation. Because
flavonoids are known for their antioxidant and anti-inflammatory activities,
this result further supports the biological relevance of the plant extracts
used in the hydrogel. The quercetin calibration curve showed good linearity
(Fig 04), validating the assay.
Table 3. TPC of the
extract
|
Extract
|
Total Phenolic Content (mg GAE/g)
|
Total Flavonoid Content (mg QE/g)
|
|
Curcuma longa
|
86.42 ± 1.18
|
64.78 ± 0.94
|
|
Piper nigrum
|
71.36 ± 1.05
|
52.63 ± 0.88
|
Fig. 4. Calibration
curve for Quercetin
FTIR
Study
FTIR analysis
of the extracts was performed using ALPHA II FTIR spectrophotometer (BRUKER,
Japan). When analysed alone (fig 05and 07) and with excipients (Fig 06 and 08)
it showed retention of the characteristic absorption peaks with no significant
shifting or disappearance or appearance of new peaks employed in FTIR studies.
This suggested excellent compatibility between the herbal extracts and the
chosen excipients with no significant chemical interaction while also revealing
that active phytoconstituents remained chemically stable during formulation
development.
Fig. 5. FTIR of C.
Longa extract
Fig. 6. FTIR of C.
Longa extract with excipients
Fig. 7. FTIR of P.
Nigrum extract
Fig. 8. FTIR of
P. Nigrum extract with excipients
Organoleptic
Evaluation
Visual
inspections of the hydrogel batches showed no signs of phase separation,
confirming physical stability of developed formulations (Table 04). It
transitions from yellowish brown to dark yellowish brown, and varies in
consistency from smooth to thick and smooth, with no grit or separation. These
results suggest successful gel formation and that herbal extracts and
excipients dispersed uniformly throughout the gels whereas texture changes
observed between formulated samples, indicating that polymer type and
concentration had a significant impact on the final features of the
formulation.
Table 4. Organoleptic
Evaluation of Hydrogel Formulations
|
Formulation
|
Colour
|
Consistency
|
Homogeneity
|
Grittiness
|
Phase Separation
|
|
F1–F3
|
Yellowish brown
|
Smooth
|
Good
|
Absent
|
Absent
|
|
F4–F6
|
Light brown
|
Smooth
|
Good
|
Absent
|
Absent
|
|
F7–F9
|
Brown
|
Slightly thick
|
Good
|
Absent
|
Absent
|
|
F10–F12
|
Dark yellowish brown
|
Thick and smooth
|
Excellent
|
Absent
|
Absent
|
pH
of Formulations
The pH of all
hydrogel formulations was observed using LI-120 digital pH meter (Labindia
Instruments Pvt. Ltd., India). It was observed between 6.21 and 6.51 (Table
05), indicating suitable compatibility with physiological conditions within the
upper layers of skin. Formulation F1 had the lowest pH (6.21 ± 0.05), whereas
F9 showed the highest pH (6.51 ± 0.03). The narrow pH range indicates good
stability of the formulation and compatibility between the incorporated herbal
extracts and polymers in the hydrogel system.
Viscosity
of Formulations
The viscosity
was determined using DV-E Brookfield viscometer (AMETEK Brookfield, USA). It
varied with respect to the strength of each polymer and formulation composition
(Table 05), whereby F1 exhibited the lowest viscosity of 4210 ± 42 cP, whereas,
F9 has the highest of 6246 ± 51 cP. Chitosan and other formulations including
Carbopol showed higher viscosity than sodium alginate based batches, whereas
HPMC based batches also showed relatively high viscosity. This suggests that
stronger gel networks resulted in better retention at the site of application,
but may also limit drug diffusion to some extent.
Spreadability
of Formulations
Spreadability
was inversely correlated to viscosity with F1 exhibiting the highest spreadability
(18.45 ± 0.31 g·cm/sec) and F9 the lowest (12.85 ± 0.19 g·cm/sec). This
confirms that more structured and viscous gels are less easily spread, whereas
less viscous gels spread more readily. A moderate spreadability is desirable
for topical hydrogel application because it ensures ease of application without
excessive flow from the skin surface.
Swelling
Index of Formulations
The swelling
index increased across all batches, with F9 exhibiting the highest swelling
(148.3 ± 3.2%) and F1 the lowest (112.4 ± 2.1%). Importantly, this illustrates
how polymer composition governs liquid absorption and an extension of the
matrix, which can promote hydration and enable active constituents to be
released from the gel. The greater swelling of the batches containing Carbopol
could be indicative of greater water-binding capacity and possibly an improved
drug release profile.
Extrudability
of Formulations
Extrudability
values ranged from 91.5 ± 1.6 g/cm² for F1 to 76.4 ± 1.5 g/cm² for F9,
indicating that higher-viscosity formulations were more resistant to extrusion
from the tube. Although the stronger gel structure can improve residence time
but acceptable extrudability is necessary for the patient convenience and ease
of application. The F9 batch showed the best balance of gel strength and
dispensability among the tested formulations.
Table 5.
physicochemical parameters
|
Formulation
|
pH
|
Viscosity (cP)
|
Spreadability (g·cm/sec)
|
Swelling Index (%)
|
Extrudability (g/cm²)
|
|
F1
|
6.21 ± 0.05
|
4210 ± 42
|
18.45 ± 0.31
|
112.4 ± 2.1
|
91.5 ± 1.6
|
|
F2
|
6.34 ± 0.04
|
4865 ± 38
|
16.92 ± 0.28
|
124.7 ± 2.5
|
88.2 ± 1.4
|
|
F3
|
6.41 ± 0.03
|
5528 ± 45
|
14.85 ± 0.25
|
136.5 ± 2.8
|
82.4 ± 1.5
|
|
F4
|
6.28 ± 0.06
|
4385 ± 41
|
17.88 ± 0.26
|
118.2 ± 2.2
|
90.1 ± 1.7
|
|
F5
|
6.39 ± 0.05
|
5124 ± 47
|
15.73 ± 0.22
|
129.8 ± 2.6
|
85.6 ± 1.3
|
|
F6
|
6.46 ± 0.04
|
5872 ± 49
|
13.94 ± 0.24
|
142.1 ± 3.1
|
79.5 ± 1.4
|
|
F7
|
6.31 ± 0.05
|
4725 ± 44
|
16.84 ± 0.29
|
120.6 ± 2.4
|
87.8 ± 1.5
|
|
F8
|
6.43 ± 0.04
|
5488 ± 46
|
14.62 ± 0.21
|
133.7 ± 2.7
|
81.9 ± 1.6
|
|
F9
|
6.51 ± 0.03
|
6246 ± 51
|
12.85 ± 0.19
|
148.3 ± 3.2
|
76.4 ± 1.5
|
|
F10
|
6.26 ± 0.04
|
4568 ± 43
|
17.24 ± 0.27
|
116.8 ± 2.3
|
89.3 ± 1.6
|
|
F11
|
6.38 ± 0.05
|
5296 ± 45
|
15.38 ± 0.23
|
128.4 ± 2.5
|
84.5 ± 1.4
|
|
F12
|
6.49 ± 0.04
|
6015 ± 50
|
13.42 ± 0.20
|
141.6 ± 2.9
|
78.6 ± 1.5
|
In
Vitro Antioxidant Activity (DPPH Assay)
The DPPH
radical scavenging activity increased from 62.4 ± 1.2% in F1 to 78.5 ± 1.5% in
F9, indicating that the optimized formulation has maximum antioxidant
potential. This increased activity could be based on the prolonged retention
and better release of herbal actives from the polymeric matrix, along with are
rich in phenolic and flavonoid content of the plant extracts. Therefore, F9 may
be a good candidate for antioxidant topical hydrogel.
Table 6. In vitro
antioxidant activity and anti inflammatory activity
|
Formulation
|
% Radical Scavenging Activity
|
% Inhibition of Protein Denaturation
|
|
F1
|
62.4 ± 1.2
|
58.4 ± 1.1
|
|
F2
|
66.8 ± 1.1
|
62.5 ± 1.2
|
|
F3
|
71.2 ± 1.3
|
66.7 ± 1.3
|
|
F4
|
64.5 ± 1.0
|
60.2 ± 1.0
|
|
F5
|
69.4 ± 1.2
|
64.8 ± 1.1
|
|
F6
|
73.8 ± 1.4
|
69.4 ± 1.2
|
|
F7
|
67.1 ± 1.1
|
63.1 ± 1.1
|
|
F8
|
72.6 ± 1.3
|
68.6 ± 1.3
|
|
F9
|
78.5 ± 1.5
|
74.2 ± 1.4
|
|
F10
|
65.2 ± 1.2
|
61.5 ± 1.2
|
|
F11
|
70.8 ± 1.1
|
66.9 ± 1.1
|
|
F12
|
75.4 ± 1.3
|
71.3 ± 1.3
|
Fig. 9. DPPH study
of Formulation F1–F12
In
Vitro Anti-Inflammatory Activity
The egg albumin
denaturation assay showed a similar trend to the antioxidant study, with F1
exhibiting 58.4 ± 1.1% inhibition and F9 showing the highest anti-inflammatory
activity at 74.2 ± 1.4%. Thus, this indicates that the formulation successfully
minimized the denaturation of proteins and hence inflammatory process. The best
performance of F9 signifies the optimum bioavailability from bioactive
compounds and suitable polymeric matrix.
Fig. 10. In-Vitro
anti- Inflammatory activity study of Formulation F1–F12
In
Vitro Antibacterial Activity of F9 Optimized Batch
The optimized
F9 formulation demonstrated clear antibacterial activity against both Staphylococcus
aureus and Escherichia coli, with zones of inhibition of 16.5 ± 0.3
mm and 18.5 ± 0.4 mm, respectively, compared with the standard values of 18.9 ±
0.4 mm and 21.1 ± 0.2 mm. Although the activity was slightly lower than the
standard antibiotic, the hydrogel still showed appreciable antimicrobial
potential, which may be due to the combined effect of Curcuma longa and Piper
nigrum and effective delivery of active compounds from the gel matrix.
%
Zone inhibition against S. Aureus
A = Control; B= Standard and C= Hydrogel
|
%
Zone inhibition against E. Coli
A = Control; B= Standard and C= Hydrogel
|
Fig. 11. In Vitro
Antibacterial Activity of F9 Optimized Batch
Overall
Interpretation
In general, the
herbal hydrogel formulations were stable from a physical point of view in terms
of skin compatibility and possessed significant antioxidant, anti-inflammatory
and antimicrobial activities. Of all batches, F9 is the most successful
formulation due to its elevated swelling index, significant antioxidant and
anti-inflammatory activity and strong antibacterial property; however, higher
viscosity, lower spreadability and low extrudability suggest a compact polymer
network, probably responsible for adhesion and more permanent residence at the
site of application.
CONCLUSION
The present study
successfully formulated a stable and skin-compatible polyherbal hydrogel from Curcuma
longa and Piper nigrum extracts. The optimized F9 formulation showed
the best overall balance of physicochemical properties and biological activity
that indicated strong antioxidant, anti-inflammatory, and antimicrobial
potential. The results support the use of this herbal hydrogel as a suitable
topical formulation for further preclinical and clinical investigation.
REFERENCES
1. Terefe
EM. African traditional medicine: historical legacy, colonial disruption, and
pathways for integration into modern healthcare. Front Pharmacol. 2026;17:1842857.
doi: 10.3389/fphar.2026.1842857.
2. Patel
GM, Shah AA, Prajapati GB, Sriamornsak P. Transforming herbal medicines:
integrating traditional knowledge with modern pharmaceutical advancements. Sci
Eng Health Stud. 2025;19:25010001. doi: 10.69598/sehs.19.25010001.
3. Pal
A, Panigrahi SK, Santra A. Broadening the avenues of complementary medicine and
way forward to integrate it with evidence-based modern medicine research – a
need of the hour. Indian J Community Health [Internet]. 2025 Apr 30 [cited 2026…].
4. Etaware PM. Medicinal plants, synthetic drugs
or clinical therapy: the safest option against the pandemic COVID-19
coronavirus. Pharmacology and Alternative Medicine Academic Journal.
2020;5(1):1-13.
5. Aarthi
S, Suresh J, Leela NK, Prasath D. Multi environment testing reveals
genotype-environment interaction for curcuminoids in turmeric (Curcuma longa
L.). Ind Crops Prod. 2020;145:112090.
6. Narwaria
A, Chakrabarty AK, Bishayee S, Mohanty S, Banerjee D, Sharma S, Katiyar CK,
Dubey SK. Preparation, evaluation, and in vitro studies of sustained-release
topical hydrogel of Curcuma longa L. targeting skin disorders. Int J Ayurveda
Res. 2024;5(2):94-107. doi: 10.4103/ijar.ijar_30_24.
7. Wang
G, Zhou X, Pang X, Ma K, Li L, Song Y, Hou D, Wang X. Pharmacological effects,
molecular mechanisms and strategies to improve bioavailability of curcumin in
the treatment of neurodegenerative diseases. Front Pharmacol. 2025;16:1625821.
doi: 10.3389/fphar.2025.1625821.
8. Curcumin (Curcuma longa): applications in
clinical, regenerative and aesthetic dermatology. J Skin. 2026;10(3):s782.
doi:10.25251/526zed25.
9. Agustina
R, Setyaningsih D. Solid dispersion as a potential approach to improve
dissolution and bioavailability of curcumin from turmeric (Curcuma longa L.).
Int J Appl Pharm. 2023;15(5):37-47.
10. Bhadange
V, Jogdand S, Kawtikwar A, Kawtikwar P. Design, development and evaluation of
curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance
solubility and improve efficacy in MCF-7 cell line by quality by design. Ann
Pharm Fr. 2025;83(6):1175-1188.
11. Sinha
S, Chaudhuri P, Chatterjee S, Kumar A. Anthropometric and physiological
assessment of tribal populations in West. Probecell Sci. 2026;3(1):1-10.
12. Patel
MK, Shah S, Dubey BK, Basedia DK, Jain PK. Formulation and characterization of
curcumin-loaded aquasomes for topical fungal treatment. Asian J Pharm Res Dev.
2025;13(1):10-14.
13. Gorgani
L, Mohammadi M, Najafpour GD, Nikzad M. Piperine—the bioactive compound of
black pepper: from isolation to medicinal formulations. Compr Rev Food Sci Food
Saf. 2017;16:124-140. doi: 10.1111/1541-4337.12246.
14. Chaudhri
SK, Jain S. A systematic review of piperine as a bioavailability enhancer. J
Drug Deliv Ther [Internet]. 2023 Apr 15 [cited 2026 Jun 6];13(4):133-136.
15. Alawi
MN, Ardana ZN, Putra RP, Tirta RBMD, Asepputra MA. Analgesic activity of a
transdermal patch containing ethanol extract of Piper nigrum L. fructus with
various penetration enhancers in mice. J Basic Med Vet. 2026;15(1):141-150.
doi: 10.20473/jbmv.v15i1.83260.
16. Raghunath
I, Koland M, Narayanan AV. Piperine: a possible permeation enhancer for oral
protein delivery. J Appl Pharm Sci. 2024;14(4):35-45.
17. Chopra
B, Dhingra AK, Kapoor RP, Prasad DN. Piperine and its various physicochemical
and biological aspects: a review. Open Chem J. 2017;3:75-96.
18. Meghwal
M, Goswami TK. Chemical composition, nutritional, medicinal and functional
properties of black pepper: a review. Open Access Sci Rep. 2012;1:1-5.
19. Salehi
B, Zakaria ZA, Gyawali R, et al. Piper species: a comprehensive review on their
phytochemistry, biological activities and applications. Molecules.
2019;24:1364. doi: 10.3390/molecules24071364.
20. Libby
P, Smith R, Rubin EJ, Glassberg MK, Farkouh ME, Rosenson RS. Inflammation
unites diverse acute and chronic diseases. Eur J Clin Invest.
2024;54(11):e14280.
21. Pires PC, Damiri F, Nazarzadeh Zare E, Hasan
A, Esmaeely Neisiany R, Veiga F, et al. A review on natural biopolymers in
external drug delivery systems for wound healing and atopic dermatitis. Int J
Biol Macromol. 2024;263(Pt 1):130296.
22. Desai
SR, Bhagwat DA, Singh AK, Kumbhar RB, Khan J. Bioadhesive polymers in
transdermal formulations for skin disorders. Curr Opin Pharmacol.
2025;83:102544.
23. Straccia
MC, d'Ayala GG, Romano I, Oliva A, Laurienzo P. Alginate hydrogels coated with
chitosan for wound dressing. Mar Drugs. 2015 May 11;13(5):2890-2908. doi:
10.3390/md13052890.
24. Saberian
M, Safari Roudsari R, Haghshenas N, Rousta A, Alizadeh S. How the combination
of alginate and chitosan can fabricate a hydrogel with favorable properties for
wound healing. Heliyon. 2024 Jun 3;10(11):e32040. doi: 10.1016/j.heliyon.2024.e32040.
25. Awari A, Kaushik D, Oz F, Kumar M. Deep
eutectic solvents assisted green extraction and bioevaluation of phenolic
compounds from Piper nigrum and Murraya koenigii. Food Chem. 2025;493(Pt
3):145931.
26. Zheng
J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for prevention and treatment of
cancers. Nutrients. 2016;8:495. doi: 10.3390/nu8080495.
27. Xiao
J, Liang Y, Sun T, Liu M, He X. A functional dual responsive CMC/OHA/SA/TOB
hydrogel as wound dressing to enhance wound healing. Sci Rep. 2024 Nov
6;14(1):26854. doi: 10.1038/s41598-024-78044-8.
28. Ouko
JO, Wanjala C, Wanzala M, Mutai C, Mandillah L. Ethnobotanical assessment of
herbal medicine practices for cancer treatment among traditional medicine
practitioners in Kenya. Afr J Empir Res. 2024;5(3):1149-1165.
29. Lowance
M, Franco J, Wang E, Milanaik R. Navigating nature’s remedies: herbal and
botanically derived complementary alternative medicine for children. Curr Opin
Pediatr. 2025;37(5):495-507. doi: 10.1097/MOP.0000000000001493.
30. Hoang
HM, Yong LY, Au KH, Pham TM, Pham VAT, Dang THT, Gao YX. Traditional Vietnamese
herbal remedies for gout: a comprehensive review of mechanisms, practical
applications, and therapeutic potential. J Appl Pharm Sci. 2026;16(02):055-069.
31. Kumari
P, Bais S. Formulation and pharmacological evaluation of herbal gel containing
Curcuma longa. INNOSC Theranostics Pharmacological Sciences. 2023;5:1-6. doi:
10.36922/itps.287.
32. Huma
S, Khan HMS, Sohail M, Akhtar N, Rasool F, Majeed F, Daniyal M. Development,
in-vitro characterization and assessment of cosmetic potential of Beta vulgaris
extract emulsion. J Herbal Med. 2020;23:100372. doi:
10.1016/j.hermed.2020.100372.
33. Kokate CK. Handbook of practical
pharmacognosy. 4th ed. Vallabh Prakashan; 1994.
34. Mohammad G, Omram A, Hussein H. Antibacterial
and phytochemical analysis of Piper nigrum using gas chromatography–mass
spectrum and fourier-transform infrared spectroscopy. 2016;8:977-996.
35. Sawant KR, Khan ZK. Formulation and
evaluation of herbal hydrogel for wound healing. Int J Res Publ Rev.
2025;6(5):11096-11106.
36. Faruk A, Gole V, Dhumale P, Dabhade S,
Doifode D, Netkar R, Kokate S, Ambadkar G. Formulation and evaluation of a
carbopol-based herbal hydrogel containing Curcuma longa and Nigella sativa
extracts with antioxidant and anti-inflammatory activities for enhanced wound
healing. Biochem Cell Arch. 2025;26:599-614. doi: 10.51470/BCA.2026.26.1.599.
37. Safavi
N, Ohadi M, Dehghannoudeh G, Sharifi I, Salarkia E, Dabiri S, Sharifi F.
Formulation and evaluation of amphotericin B emulsion gel against Leishmania
major in a murine model: parasite burden, gene expression, and
histopathological profiling. Parasitology Research. 2026;125(1):17. doi:
10.1007/s00436-026-08626-0.
38. Bhoyar S, Bobade N, Pande SD, Murkute M,
Kolhe A, Vaishnav H. Formulation and evaluation of topical hydrogel containing
luliconazole for the treatment of fungal infections. Int J Res Publ Rev.
2023;4(6):783-792.
39. Attri DS, Rathour A, Ray R, Kumar V.
Formulation and evaluation of hydrogel for topical drug delivery of Zingiber
officinale Rosc. and Withania somnifera (L.) Dunal to increase the
bioavailability of oils for the treatment of arthritis. Ann Phytomed.
2023;12(1):285-294. doi: 10.54085/ap.2023.12.1.25.
40. Baliyan
S, Mukherjee R, Priyadarshini A, Vibhuti A, Gupta A, Pandey RP, Chang CM.
Determination of antioxidants by DPPH radical scavenging activity and
quantitative phytochemical analysis of Ficus religiosa. Molecules.
2022;27(4):1326. doi: 10.3390/molecules27041326.
41. Tharindu Madhuranga H, Samarakoon N. In vitro
anti-inflammatory egg albumin denaturation assay: an enhanced approach. J Nat
Ayurvedic Med. 2023;7:000411.
42. Bhavsar S, Humbal B, Sadariya K, Baria T.
Evaluation of the in vitro antibacterial activity and minimum inhibitory
concentration of Curcuma longa L., Ocimum sanctum L. and Piper nigrum L.
ethanolic and aqueous extracts. Ann Phytomed. 2022;11:10.54085/ap.2022.11.1.53.
43. Tharindu
Madhuranga, H., & Samarakoon, N. (2023). In vitro anti-inflammatory egg
albumin denaturation assay: An enhanced approach. Journal of Natural &
Ayurvedic Medicine, 7, 000411.
44. Bhavsar,
S., Humbal, B., Sadariya, K., & Baria, T. (2022). Evaluation of the in
vitro antibacterial activity and minimum inhibitory concentration of Curcuma
longa L., Ocimum sanctum L. and Piper nigrum L. ethanolic and aqueous extracts.
Annals of Phytomedicine: An International Journal, 11,
10.54085/ap.2022.11.1.53.